Efficacy and Safety of a Novel Adsorber for LPS-Selective Hemosorption (Experimental Study)
https://doi.org/10.15360/1813-9779-2018-6-51-60
Abstract
The purpose of the study is to evaluate the in vitro and ex vivo effectiveness and safety of a new device for extracorporeal blood purification.
Materials and methods. The sorption properties and safety of hemoperfusion using the LPS sorption column that employs hypercrosslinked styrene-divinylbenzene copolymer.
were studied using three different models:
1) Escherichia coli endotoxin solution in aqueous 0.9% NaCl solution with an assessment of the efficacy of endotoxin elimination,
2) donor erythrocyte suspension with assessment of the hemoperfusion column safety for blood cells,
3) whole donor blood with assessment of hemosorption efficacy and hemoperfusion safety of the new column.
Results. There was a 18.5-fold decrease in the endotoxin concentration in 0.9% sodium chloride solution over
2 hours of perfusion vs. the baseline, while maintaining the residual sorption capacity of the column. Perfusion of RBC suspension and freshly prepared donor blood through the new LPS column did not demonstrate the emergence and growth of cytolytic markers; on the contrary, a two-fold decrease in the concentration of free hemoglobin containing in the RBC suspension was observed. There was a two-fold decrease in the vitamin B12 concentration, a 3.54-fold decrease in β2-microglobulin and a 2.5-fold decrease in creatinine levels. The atomic force microscopy did not find critical impairment of the morphology of erythrocyte membranes.
Conclusion. In vitro and ex vivo tests demonstrated reliable experimental data on the effectiveness and safety of the device that employs a hypercrosslinked styrene-divinylbenzene copolymer for LPS-selective hemosorption, which was not inferior to one of analogues for hemosorption currently employed in clinical practice.
About the Authors
Sergey E. KhoroshilovRussian Federation
25 Petrovka Str., Bldg. 2, 107031 Moscow;
3 Gospitalnaya Square, 105229 Moscow
Artem V. Nikulin
Russian Federation
25 Petrovka Str., Bldg. 2, 107031 Moscow;
3 Gospitalnaya Square, 105229 Moscow
Ivan V. Bessonov
Russian Federation
7 Nobel Str., Skolkovo, 143026 Moscow
Alexander S. Morozov
Russian Federation
7 Nobel Str., Skolkovo, 143026 Moscow
Ivan V. Yarema
Russian Federation
20 Delegatskaya Str., Bldg 1, 127473 Moscow
References
1. Rudnov V.A., Belsky D.V., Dekhnich A.V., Matveyev A.S., Gievskaya O.L., Drozd A.V., Fesenko A.A., Malkova O.G., Cherkasov G.V., Bagin V.A., Belsky D.V., Piontek A.E., Noskov I.Yu., Kolmakov V.V., Lopushov D.V., Grigoryev E.V., Matskevich V.A., Bochanova E.N., Kucherenko I.V., Gelfand B.R., Popov T.V., Fridkin V.I., Berezhansky B.V., Protsenko D.N., Ignatenko O.V., Kulabukhov V.V., Yarustovsky M.B., Veksler N.Yu., Klimova E.A., Fedorova O.B., Belotserkovsky B.Z., Churadze B.T., Shiryaev M.I., Belsky V.A., Streltsova E.I., Lashchenkova E.V., Samatov I.Yu., Vereshchinsky A.M., Belotskaya T.G., Makienok I.V., Latyshev P.E., Tolkach A.B., Zubareva N.A., Lyapustin S.B., Starodubtseva N.V., Perepelin R.V., Volkova Yu.V., Fedotov Yu.N., Buzanov D.V., Panychek M.M., Gorodkov S.Yu., Dudnikov V.F., Pyataev N.A., Zverkov A.V., Burdyanskaya Yu.V., Zuzov S.A., Nikolaev S.V., Semenkova G.V., Mukhacheva S.Yu., Sivkov O.G., Kukhterin A.A., Shen N.P., Shvechkova M.V., Berestov A.L., Ishmukhametov I.Kh., Zolotukhin K.N., Leshkova V.E., Abubakirova A.I., Lykov A.V., Nasretdinova S.M., Mironov P.I., Ushakov V.A., Slobodenyuk E.V., Gorokhovsky V.S., Kokarev E.A., Plotkin L.L., Palyutin Sh.Kh., Matveyev A.S. Infections in Russian ICUs: results of the nationwide multicenter study. Klinicheskaya Mikrobiologiya i Antimikrobnaya Khimioterapiya. 2011; 13 (4): 294–303. [In Russ.]
2. Nesseler N., Defontaine A., Launey Y., Morcet J., Mallédant Y., Seguin P. Long-term mortality and quality of life after septic shock: a follow-up observational study. Intensive Care Med. 2013; 39 (5): 881–888. DOI: 10.1007/s00134-013-2815-1. PMID: 23358541
3. Gyulazyan N.M., Belaya O.F., Malov V.A., Pak S.G., Volchkova E.V. Lipopolysaccharides/endotoxins of gram-negative bacteria: their role in the development of intoxication. Epidemiologiya i Infektsionnye Bolezni. 2014; 2: 11–16. [In Russ.]
4. Titov V.N., Dugin S.F. Translocation syndrome, bacterial lipopolysaccharides, impaired biological inflammatory reactions and blood pressure disorders (a lecture). Klinicheskaya Laboratornaya Diagnostika. 2010; 4: 21–37. PMID: 20527077. [In Russ.]
5. Shimizu T., Miyake T., Kitamura N., Tani M., Endo Y. Endotoxin adsorption: direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX). Transfus. Apher. Sci. 2017; 56 (5): 682v688. DOI: 10.1016/j.transci.2017.08.015. PMID: 28923774
6. Bauquier J.R., Tennent-Brown B.S., Tudor E., Bailey S.R. Effects of polymyxin-B on TNF-production in equine whole blood stimulated with three different bacterial toxins. J. Vet. Pharmacol. Ther. 2018; 41 (1): e35-e39. DOI: 10.1111/jvp.12445. PMID: 28804940
7. Lipcsey M., Tenhunen J., Sjölin J., Frithiof R., Bendel S., Flaatten H., Kawati R., Kuitunen A., Tønnessen T.I., Rubertsson S. Abdominal Septic Shock — Endotoxin Adsorption Treatment (ASSET) — endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial. Trials. 2016; 17 (1): 587. DOI: 10.1186/s13063-016-1723-4. PMID: 27931259
8. Malard B., Lambert C., Kellum J.A. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med. Exp. 2018; 6 (1): 12. DOI: 10.1186/s40635-018-0177-2. PMID: 29728790
9. Gendel L.L., Sokolov A.A., Gubanova S.N., Adamova I.Yu., Levashov P.A. First clinical experience of using column for LPS-adsorption of Toxipak in treatment of sepsis patients. Vestnik Anesteziologii i Reanimatologii. 2017: 14 (5): 42-50. DOI: 10.21292/2078-5658-2017-14-5-42-50. [In Russ.]
10. Morozov A.S., Kopitsyna M.N., Bessonov I.V., Karelina N.V., Nuzhdina A.V., Sarkisov I.Y., Pavlova L.A., Tsyurupa M.P., Blinnikova Z.K., Davankov V.A. A selective sorbent for removing bacterial endotoxins from blood. Rus. J. Physic. Chem. A. 2016; 90 (12): 2465-2470. DOI: 10.7868/S0044453716120165. [In Russ., In Engl.]
11. Morozov A.S., Bessonov I.V., Nuzhdina A.V., Pisarev V.M. Sorbents for extracorporeal removal of toxic substances and molecules with adverse biological activity (review). Obshchaya Reanimatologiya = General Reanimatology. 2016; 12 (6): 82-107. DOI: 10.15360/1813-9779-2016-6-82-107. [In Russ., In Engl.]
12. Shoji H., Minaga M., Sakai Y., Kunitomo T., Takeyama T., Tani T., Kodama M. Design and development of endotoxin detoxifying column PMX and its clinical application. Japan. J. Artif. Organs. 1993; 22 (1): 204-211.
13. Decree of the Government of the Russian Federation, January 26, 2010 No. 29 (ed. September 4, 2012) «On approval of technical regulations on safety requirements for blood, its products, blood-substituting solutions and technical means used for transfusions and infusions». http://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n =135176&fld=134&dst=100178,0&rnd=0.5630885760251418#045647 28471827679. [In Russ.]
Review
For citations:
Khoroshilov S.E., Nikulin A.V., Bessonov I.V., Morozov A.S., Yarema I.V. Efficacy and Safety of a Novel Adsorber for LPS-Selective Hemosorption (Experimental Study). General Reanimatology. 2018;14(6):51-60. https://doi.org/10.15360/1813-9779-2018-6-51-60